Rational use of corticosteroids in covid-19-a review

N. Vamsi Krishna V; Siva Ramesh Chikkala

N. Vamsi Krishna V Department of Pharmacy, Aditya College of Pharmacy, ADB Road, Surampalem, East Godavari district, Andhra Pradesh, India
vamsi.vasabhakthula@gmail.com
Siva Ramesh Chikkala Department of Pharmacy, Aditya College of Pharmacy, ADB Road, Surampalem, East Godavari district, Andhra Pradesh, India

Abstract

The novel coronavirus has spread globally and affected many people and health care systems equally. W.H.O recommends steroid therapy for 7-10 days only in patients with severe disease. Lung injury in covid-19 is due to the systematic immune response of the patient, which leads to an increase in the severity of the condition. Evidence has shown that the use of corticosteroids is an easily accessible and beneficial treatment option in overcoming ARDS and hyper inflammation conditions. The main aim of this review is to provide an overview of the rational use of corticosteroids in the management of covid-19.

Keywords: Corticosteroid, Covid-19, Lung injury

Downloads

Download data is not yet available.

References

Moore J, June C. Cytokine release syndrome in severe COVID19: lessons from arthritis and cell therapy in cancer patient point to therapy for severe disease. Science. 2020:368(6490);473-474. doi:10.1126/science.abb8925.

Siddiqi HK, Mehra MR. COVID-19 illness in native and immune suppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405.

Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19-preliminary report. RECOVERY Collaborative Group N Engl J Med. 2020. doi: 10.1056/NEJMoa2021436.

ClinicalTrials.gov. Accessed September 21, 2020. https://clinical trials.gov.

Brotman DJ, Girod JP, Posch A, et al. Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res 2006; 118: 247–52.

Villar J, Confalonieri M, Pastores SM, Meduri GU. Rationale for prolonged corticosteroid treatment in the acute respiratory distress syndrome caused by coronavirus disease 2019. Crit Care Explor 2020; 2: e0111.

The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020. doi:10.10001/jama.2020.17023.